QDEL  valuation analysis

Name: Quidel Corporation
Description: Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $4.97B (707th)
Sales(TTM): $1.86B (775th)
Earnings(TTM): $948.13M (245th)

FFER: 0.47*
Actual price: $116.77
* Earnings were reported Jul 28, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
  • Quidel Corporation's sales grew by 231.6% ($561.58M to $1.86B) over one year against a market average growth of 20.1%.
Earnings / MarketCap
Quidel Corporation
"Diagnostics & Research" industry
Sales / MarketCap
Quidel Corporation
"Diagnostics & Research" industry
Book / MarketCap
Quidel Corporation
"Diagnostics & Research" industry
Equity / Assets
Quidel Corporation
"Diagnostics & Research" industry